In an increasingly tech-driven world, specialization in bioinformatics will set graduate students in Tufts’ biology master’s ...

MedGenome unveils MetaSeq, a groundbreaking blood test capable of detecting over 1,400 pathogens in just five days, enhancing ...

In the fast-changing landscape of the health and wellness sector, businesses require more than generic solutions. They seek platforms that can evolve in accordance with their distinct vision, branding ...

A new study suggests that applying a deep learning algorithm to routine abdominal CT scans could help identify fall risk ...

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

MedGenome expands its infectious disease testing portfolio with MetaSeq, a single test that detects over 1,400 pathogens: Our Bureau, Bengaluru Thursday, February 5, 2026, 14:15 H ...

The global spatial biology market is projected to grow at a compound annual growth rate (CAGR) of approximately 15% over the ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast ...

Deep-learning model decodes the regulatory effects of DNA changes ...

In the evolving landscape of oncology, skin cancer diagnosis stands out as a domain where the synergy between AI and multimodal imaging is rapidly changing ...

Heart failure (HF) is a chronic and progressive cardiovascular condition associated with significant morbidity, mortality and ...